DrugCard: AI-Powered Pharmacovigilance for Efficient Adverse Event Monitoring

DrugCard is an AI-enabled data intelligence platform designed to streamline drug safety routines through continuous and traceable adverse event monitoring. It automates local literature screening for pharmacovigilance professionals, offering multilingual support, advanced OCR technology, and real-time regulatory updates. Ideal for pharmaceutical companies and healthcare organizations, DrugCard enhances efficiency and compliance in drug safety management.

Key Features:

• Adverse Event Monitoring: Continuous tracking of adverse events with 99% OCR accuracy for poorly scanned texts.
• Multilingual Support: Covers 100+ languages and 66+ countries, with automatic translation for reviews.
• Regulatory Compliance: Adheres to FDA CFR 21 Part 11, ICH E2B(R2)/R3 standards, and ISO/IEC 27001:2013 certifications.
• Automated Reporting: Provides weekly reports, instant email notifications, and audit trails.
• Global Coverage: Monitors 1500+ local journals, including EMA, WHO, FDA, and regional health authorities.
• Real-Time Alerts: Instant updates on regulatory changes and drug safety updates.
• Pharmacovigilance Services: Includes medical literature monitoring, signal management, and training.

Pricing:

DrugCard offers a free 2-week trial, with enterprise plans available for customized solutions.

Conclusion:

DrugCard is a cutting-edge AI platform that revolutionizes pharmacovigilance by automating complex workflows, ensuring regulatory compliance, and saving up to 70% of time compared to traditional methods.